Paraurethral Transplantation of Autologous Muscle Derived Stem Cells for Treatment of Stress Incontinency

Inclusion Criteria: * Female * Stress Urinary Incontinence symptoms * Urodynamic stress incontinence confirmed with multichannel urodynamic testing * positive cough stress test * urgency score \< stress score * Patient's age between 40 - 65 years * Desire to surgical correction of stress urinary incontinence or inadequate response to conservative treatment of SUI Exclusion Criteria: * Post-void residual volume \>100cc * Detrusor overactivity on preoperative multichannel urodynamic testing * History of previous synthetic, biologic or fascial sub-urethral sling or any other surgery on external genitalia, bladder neck, bladder or urethra * Desires future childbearing * Chronic inguinal or vulvar abscess or history of Hidradenitis Suppurative * History of bleeding diathesis or current anti-coagulation therapy * Inguinal lymphadenopathy or inguinal/vulvar mass * Current genitourinary fistula or urethral diverticulum * Current sever cystocele or rectocele * Active urinary infection * Non-treated urge incontinency or any significant voiding dysfunction * Neuromuscular disorders * Uncontrolled Diabetes * Reversible cause of incontinence (i.e. drug effect) * Contraindications for surgery